Atherosclerotic Lesion Progression Changes Lysophosphatidic Acid Homeostasis to Favor its Accumulation-Reference-Cited by-同舟云学术

Atherosclerotic Lesion Progression Changes Lysophosphatidic Acid Homeostasis to Favor its Accumulation

Published:2010-06 Issue:6 Volume:176 Page:3073-3084
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Bot Martine,Bot Ilze,Lopez-Vales Rubén,van de Lest Chris H.A.,Saulnier-Blache Jean Sébastien,Helms J. Bernd,David Samuel,van Berkel Theo J.C.,Biessen Erik A.L.

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference46 articles.

1. Atherosclerosis, an inflammatory disease;Ross;N Engl J Med,1999

2. Current concepts of the pathogenesis of the acute coronary syndromes;Libby;Circulation,2001

3. Mechanisms of plaque vulnerability and rupture;Shah;J Am Coll Cardiol,2003

4. Why do plaques rupture?;Falk;Circulation,1992

5. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions;Siess;Proc Natl Acad Sci U S A,1999

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spatial Metabolomics Identifies LPC(18:0) and LPA(18:1) in Advanced Atheroma With Translation to Plasma for Cardiovascular Risk Estimation;Arteriosclerosis, Thrombosis, and Vascular Biology;2024-03

2. Identification of key upregulated genes involved in foam cell formation and the modulatory role of statin therapy;International Immunopharmacology;2023-06

3. Emerging roles of lysophosphatidic acid receptor subtype 5 (LPAR5) in inflammatory diseases and cancer;Pharmacology & Therapeutics;2023-05

4. Classes of Lipid Mediators and Their Effects on Vascular Inflammation in Atherosclerosis;International Journal of Molecular Sciences;2023-01-13

5. Preclinical detection of lysophosphatidic acid: A new window for ovarian cancer diagnostics;Talanta;2022-09